Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral Abnormalities in Adulthood: Clinical Rescue by D-Serine | PLOS ONE
Frontiers | D-serine as a gliotransmitter and its roles in brain development and disease
Metabolism of the neuromodulator d-serine | SpringerLink
Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia - Ju-Chun Pei, Wei-Li Hung, Bei-Xuan Lin, Min-Han Shih, Liang-Yin Lu, Da-Zhong Luo, Hwan-Ching ...
Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists: Cell
Pharmacotherapy of cognitive deficits in schizophrenia | CNS Spectrums | Cambridge Core
D-serine in physiological and pathological brain aging
Clinical and biochemical study of D-serine metabolism among schizophre | NDT
D-serine amino acid molecule, illustration - Stock Image - F030/5531 - Science Photo Library
Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion | Molecular Psychiatry
The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond. | Semantic Scholar
Model for D-serine signaling in the brain. D-serine is synthesized from... | Download Scientific Diagram
D-serine | C3H7NO3 - PubChem
Effects of D-serine on auditory plasticity. (A) Line graph of % change... | Download Scientific Diagram
Novel Treatment for the Most Resistant Schizophrenia: Dual Activation of NMDA Receptor and Antioxidant | Bentham Science
D-Serine in Neuropsychiatric Disorders: New Advances
The Gliotransmitter d-Serine Promotes Synapse Maturation and Axonal Stabilization In Vivo | Journal of Neuroscience
Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction | PNAS
Glutamate and Schizophrenia: From Theory to Treatment Implications
d‐Amino acids in the brain: d‐serine in neurotransmission and neurodegeneration - Wolosker - 2008 - The FEBS Journal - Wiley Online Library
D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial - The Lancet Psychiatry
D-Amino Acid Oxidase Inhibition: A New Glutamate Twist for Clozapine Augmentation in Schizophrenia? - Biological Psychiatry
Research Breakdown on D-Serine - Examine
D-serine for Schizoaffective Disorder Clinical Trial 2023 | Power
Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral Abnormalities in Adulthood: Clinical Rescue by D-Serine | PLOS ONE
D-serine amino acid molecule. Enantiomer of L-serine. Skeletal formula Stock Photo - Alamy
